Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells
about
The retinoid X receptors and their ligandsTargeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast CancerNuclear actions of insulin-like growth factor binding protein-3Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusionIGF binding proteins in cancer: mechanistic and clinical insightsIdentification and characterization of fully human anti-CD22 monoclonal antibodies.Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.Isotretinoin and FoxO1: A scientific hypothesis.Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.Guidelines on the management of Waldenström macroglobulinaemia.Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha.Transfusion-related acute lung injury: a literature review.Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.Hypoxia Suppresses Spontaneous Mineralization and Osteogenic Differentiation of Mesenchymal Stem Cells via IGFBP3 Up-Regulation.Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express Aurora kinase A.A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling.IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB.SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses.Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR.Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis.The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model.
P2860
Q24562747-7C510BDD-0B22-42F5-8977-CA04A2034D24Q26801886-C9C7F937-044D-412C-9196-CFC1CE112371Q28080513-89B4B911-F8B7-40B7-911D-85A0DE9FF199Q28221912-F071FB97-481E-489D-B25E-6C574E5B7ABEQ28237971-352FC5F7-6D61-4A5B-B792-8DD84F3C5A85Q33523255-993A0BE9-C215-4E3C-B9BF-F866C56E3300Q33632210-67E37E1B-4D01-4C21-B86D-6C656DCC8720Q34440437-53216C0B-A738-4480-957C-9B1FB579411BQ35558873-C982DC0F-D544-408E-8436-469C8A68B946Q35586979-CFB86289-0D1A-41D4-AF71-A78B4B60CF2DQ35920711-03075A7D-3B31-4DA0-AAB7-E84424A21ABFQ36399851-B821C313-0F9F-4616-AF44-9AC5936B6F64Q36513180-7B981CCA-453B-44D1-8178-C9A3A7A61998Q36546623-AA7EBD95-3FC1-4BB3-8289-CD0A32F515A2Q37004744-FD8CD041-76B9-4C51-9D71-170A4328B038Q37286237-569F7B2A-953B-43FF-9BE3-01013D56029EQ37927102-FE388D69-30DA-4741-A51B-7512EA002669Q39149922-2221BF73-69A8-433E-BA11-B3874DB52FDEQ39855631-8FC2E2F8-0F50-4D0A-9692-45E8727D8418Q42277539-1B33470B-1703-4A07-A63D-D58C0652F144Q43779868-8466B374-0E3E-43E7-871E-5C53D84F8CF0Q45282577-3CCBCA3D-4F9D-4A85-8982-2BC341D34F9BQ46906878-91BDF3DC-1056-40CE-A358-5EA749E4AA60Q47546996-7F207286-1001-4E6B-9C06-1190A8B0EB56Q50692587-E2B6BA62-7F9C-4FD9-9F4E-6099854CCCC5Q51453803-1DFD4F59-9309-4BA4-92FE-FD6DBED314F4Q51488433-12F61839-5C00-4885-8468-02D7FEC49A8D
P2860
Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells
description
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Juli 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: July 2004)
@en
vedecký článok (publikovaný 2004/07/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/07/01)
@nl
наукова стаття, опублікована в липні 2004
@uk
مقالة علمية (نشرت في يوليو 2004)
@ar
name
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@ast
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@en
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@nl
type
label
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@ast
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@en
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@nl
prefLabel
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@ast
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@en
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@nl
P2093
P3181
P1433
P1476
Insulin-like growth factor bin ...... oids in myeloid leukemia cells
@en
P2093
Bingrong Liu
H Phillip Koeffler
Hirokuni Taguchi
Sakae Tanosaki
Takayuki Ikezoe
P304
P3181
P356
10.1182/BLOOD-2003-07-2203
P407
P577
2004-07-01T00:00:00Z